• In recent months, several institutional investors, including Ed Wachenheim’s Greenhaven Associates, have increased or initiated positions in Avantor, with Greenhaven adding more than 2 million shares during the quarter.
• This renewed institutional interest highlights how value-focused investors see potential in Avantor’s efforts to improve operations and expand margins, despite ongoing industry and company-specific challenges.
• With institutional buyers stepping up, we’ll now examine how this growing confidence influences Avantor’s investment narrative and its operational improvement ambitions.

Capitalize on the AI infrastructure supercycle with our selection of the 53 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.

Avantor Investment Narrative Recap

To own Avantor, you need to believe that its mix of lab consumables and bioprocessing products can eventually translate into healthier margins and a return to consistent profitability, despite flat recent sales and past losses. The recent pickup in institutional buying does not change the fact that the near term catalyst remains execution on margin improvement, while the biggest risk is that pricing pressure and weak demand keep profitability under strain.

One of the most relevant recent developments is Avantor’s upcoming Q2 2026 earnings release on July 29, 2026. With institutional investors increasing their stakes, this update takes on greater importance as a checkpoint on whether operational changes, leadership additions in quality and transformation, and ongoing bioprocessing and lab solutions initiatives are starting to show up in the income statement and support the thesis behind that renewed interest.

Yet this growing confidence also sits alongside the risk that elevated leverage and thinner margins could still surprise investors who are not fully aware of...

Avantor's narrative projects $6.9 billion revenue and $603.4 million earnings by 2029.

Uncover how Avantor's forecasts yield a $9.92 fair value, in line with its current price.

Exploring Other Perspectives

Some analysts focus on renewed buying and margin risks, while the most optimistic were already assuming about US$7.0 billion in revenue and US$421.6 million in earnings, so this fresh institutional interest could either support or challenge those upbeat expectations once new data comes through.

Explore 2 other fair value estimates on Avantor - why the stock might be worth just $9.92!

Form Your Own Verdict

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Avantor research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Avantor research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Avantor's overall financial health at a glance.

Searching For A Fresh Perspective?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 15 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• Find 41 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.